The vice president of Pharmacy Services with SSM Health Wisconsin region says the FDA did not rush in giving full approval to the Pfizer COVID-19 vaccine. Mo Kharbat says the vaccine has undergone the same rigorous regulatory review as dozens of other established vaccines. “Because it’s been available under emergengy authorization, tens of millions of doses were given already, far beyond what any normal clinical trials would allow. Normal clinical trials we would have ten or 20,000 patients enrolled,” Kharbat told WFDL news. “In this case there were more patients enrolled in the official clinical trials and tens of millions of doses given to people around the world.” Meanwhile, responding to the FDA stating it has received multiple reports of patients erroneously attempting to treat COVID-19 with a drug used by veterinarians to deworm livestock. Kharbart says “That’s dangerous.”
